|
WO0139802A1
|
|
Chimeric flavivirus vaccines
|
|
AU4256700A
|
|
Multimeric, recombinant urease vaccine
|
|
NZ336216A
|
|
Compositions for treating gastroduodenal disorders comprising a pathogen
|
|
WO9837911A1
|
|
Chimeric flavivirus vaccines
|
|
WO9817786A1
|
|
Heat inactivation of viruses in antibody preparations
|
|
WO9703360A1
|
|
HELICOBACTER VACCINE ANTIGEN RECOGNIZED BY A PROTECTIVE MONOCLONAL ANTIBODY (IgG 50)
|
|
EP0837692A1
|
|
Clostridium difficile toxins and toxoids as mucosal adjuvants
|
|
WO9703359A1
|
|
Helicobacter clpb
|
|
AU6479996A
|
|
Intranasal vaccination against gastrointestinal disease
|
|
CN1188416A
|
|
Multimeric recombinant urease vaccine
|
|
CA2219201A1
|
|
Multimeric, recombinant urease vaccine
|
|
US5919463A
|
|
Clostridium difficle toxins as mucosal adjuvants
|
|
US5686270A
|
|
Production of antigens by self-assembly of polypeptide components
|
|
US6258529B1
|
|
PCR amplification of rearranged genomic variable regions of immunoglobulin genes
|
|
AU7450094A
|
|
Monoclonal IgA antibody against respiratory syncytial virus
|
|
US6290962B1
|
|
Urease-based vaccine and treatment for helicobacter infection
|
|
PL304419A1
|
|
Urease based vaccine against heliobacter infections
|
|
US5690938A
|
|
Oral immunization with multiple particulate antigen delivery system
|
|
NZ251849A
|
|
Vaccines and antibodies against helicobacter infections
|
